Provided by Tiger Trade Technology Pte. Ltd.

ALPHA COGNITION INC

8.90
0.0000
Post-market: 8.900.00000.00%16:10 EDT
Volume:85.32K
Turnover:760.53K
Market Cap:193.50M
PE:-8.19
High:9.30
Open:8.99
Low:8.65
Close:8.90
52wk High:10.14
52wk Low:4.50
Shares:21.74M
Float Shares:15.06M
Volume Ratio:1.18
T/O Rate:0.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0868
EPS(LYR):-1.1790
ROE:-49.53%
ROA:-30.39%
PB:3.65
PE(LYR):-7.55

Loading ...

Press Release: Alpha Cognition (Nasdaq: ACOG) to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, May 14, 2026

Dow Jones
·
Apr 29

Alpha Cognition CEO to join H.C. Wainwright BioConnect investor conference

Reuters
·
Apr 27

Alpha Cognition Price Target Maintained With a $18.00/Share by HC Wainwright & Co.

Dow Jones
·
Apr 27

Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026

GlobeNewswire
·
Apr 22

BRIEF-Alpha Cognition Appoints Bethany Sensenig

Reuters
·
Apr 21

Alpha Cognition appoints Bethany Sensenig to board of directors

Reuters
·
Apr 21

Alpha Cognition Strengthens Its Board of Directors With Appointment of Bethany Sensenig

THOMSON REUTERS
·
Apr 21

Emmaus Life Sciences appoints Henry H. Du to board after Kuwahara resignation

Reuters
·
Apr 18

Alpha Cognition files Form 3 as director Bethany Sensenig reports no holdings

Reuters
·
Apr 18

Alpha Cognition Initiated at Buy by Craig-Hallum

Dow Jones
·
Apr 17

Alpha Cognition initiated with a Buy at Craig-Hallum

TIPRANKS
·
Apr 17

Alpha Cognition grants new hire options for 20,000 shares under inducement plan

Reuters
·
Apr 16

Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Apr 16

BRIEF-Alpha Cognition Inc - Enters Settlement Agreement With Galantos Pharma On April 10, 2026 - SEC Filing

Reuters
·
Apr 15

Alpha Cognition Inc - Settlement Amount Represents About 40% Discount to Estimated Market Value of Obligations - SEC Filing

THOMSON REUTERS
·
Apr 15

Analysts Offer Insights on Healthcare Companies: Alpha Cognition Inc (ACOG), Insmed (INSM) and Connect Biopharma Holdings (CNTB)

TIPRANKS
·
Apr 08

Alpha Cognition wins US patent for ALPHA-1062 traumatic brain injury treatment

Reuters
·
Apr 02

Alpha Cognition Receives Issued U.S. Patent for Alpha-1062 for Treatment of Traumatic Brain Injury

THOMSON REUTERS
·
Apr 02

Opaleye Management acquires $60,000 Alpha Cognition common shares

Reuters
·
Apr 01

Alpha Cognition to hold Annual General Meeting

Reuters
·
Mar 28